Management of parkinsonism and treatment of associated complications.
Management of Parkinson's disease is dominated by the desire to prevent the development of fluctuations, dyskinesia, and psychiatric complications, and to treat effectively these effects when they appear. Advances in the understanding of these complications and methods to manage them are reviewed.
Nutt
J G
JG
Department of Neurology, Oregon Health Sciences University, Portland, USA.
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects; D015259:Dopamine Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008134:Long-Term Care; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D011954:Receptors, Dopamine / Q000187:drug effects
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D011954:Receptors, Dopamine; D007980:Levodopa